Cargando…
Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics
Autores principales: | Su, Shan, Wang, Qian, Jiang, Shibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803365/ https://www.ncbi.nlm.nih.gov/pubmed/33463059 http://dx.doi.org/10.1002/ctm2.284 |
Ejemplares similares
-
A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010) -
dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022) -
Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks
por: Cao, Miao, et al.
Publicado: (2021) -
A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
por: Chitalia, Vipul C., et al.
Publicado: (2020) -
The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses
por: Xu, Wei, et al.
Publicado: (2018)